Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine

Sophie Wedekind / cancerresearchuk - The Bowelbabe Fund has raised more that £20 million and has announced the next wave of funded projects, including the Bowelbabe Vaccine.The post Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine appeared first on Cancer Research U…

AI Summary: The Bowelbabe Fund celebrated a £20 million fundraising milestone and unveiled plans for a Bowelbabe Vaccine initiative, drawing high‑profile support. Organizers framed the cash infusion as a catalyst for prevention and research efforts, while public endorsements highlighted momentum — and the fundraising thermometer that finally stopped making them blush.

#healthcare #publichealth #biotech #oncology #healthcarefinance #cancerresearch #researchfunding #clinicaltrials

2 months / oncodaily

3 months / oncodaily

3 months / oncodaily

3 months / bbc


Back to Top / Sat, April 4, 2026, 1:21 am / permalink 21769 / 5 stories in 3 months /




Related Stories


Introducing ISCO 2026 chairs and program highlights / 2 months

Nature study links adult thymus to longevity and cancer therapy / 3 months

National study to use genetic testing to guide cancer survivor follow-up / 2 months

UCLA unveils low-cost blood test to detect multiple cancers from one sample / 3 months

Ultrasensitive HPV blood test detects head and neck recurrence months earlier / 29 days

ESMO–EURACAN issues updated uveal melanoma guideline / 3 months

Cancer Grand Challenges awards five teams bold funding for cancer research / 4 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Telemedicine, Genetics, Venture Capital, Pfizer and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.